Gt biopharma announces trike™ for the treatment of breast and gi cancers

Beverly hills, calif., dec. 28, 2020 /prnewswire/ -- gt biopharma, inc. (otcqb: gtbp) (gtbp.pa) an immuno-oncology company focused on innovative therapies based on the company's proprietary nk cell engager (trike™) technology platform is pleased to announce the filing of u.s. and...
GTBP Ratings Summary
GTBP Quant Ranking